269 related articles for article (PubMed ID: 12678724)
1. Telomerase inhibitors as anticancer therapy.
Akiyama M; Hideshima T; Munshi NC; Anderson KC
Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):567-75. PubMed ID: 12678724
[TBL] [Abstract][Full Text] [Related]
2. How to inhibit telomerase activity for cancer therapy.
Kyo S; Inoue M
Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):613-26. PubMed ID: 12678728
[TBL] [Abstract][Full Text] [Related]
3. Anticancer therapy targeting telomeres and telomerase : current status.
Parkinson EK; Minty F
BioDrugs; 2007; 21(6):375-85. PubMed ID: 18020621
[TBL] [Abstract][Full Text] [Related]
4. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.
Jafri MA; Ansari SA; Alqahtani MH; Shay JW
Genome Med; 2016 Jun; 8(1):69. PubMed ID: 27323951
[TBL] [Abstract][Full Text] [Related]
5. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
Raymond E; Faivre S; Dieras V; Von Hoff D
Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
[TBL] [Abstract][Full Text] [Related]
6. Telomeres and telomerase: Pharmacological targets for new anticancer strategies?
Pendino F; Tarkanyi I; Dudognon C; Hillion J; Lanotte M; Aradi J; Ségal-Bendirdjian E
Curr Cancer Drug Targets; 2006 Mar; 6(2):147-80. PubMed ID: 16529544
[TBL] [Abstract][Full Text] [Related]
7. Telomerase inhibition as cancer therapy.
Saretzki G
Cancer Lett; 2003 May; 194(2):209-19. PubMed ID: 12757979
[TBL] [Abstract][Full Text] [Related]
8. Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins.
Naasani I; Seimiya H; Tsuruo T
Biochem Biophys Res Commun; 1998 Aug; 249(2):391-6. PubMed ID: 9712707
[TBL] [Abstract][Full Text] [Related]
9. Targeting human telomerase by antisense oligonucleotides and ribozymes.
Folini M; Pennati M; Zaffaroni N
Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):605-12. PubMed ID: 12678727
[TBL] [Abstract][Full Text] [Related]
10. Telomere length maintenance in aging and carcinogenesis.
Aragona M; Maisano R; Panetta S; Giudice A; Morelli M; La Torre I; La Torre F
Int J Oncol; 2000 Nov; 17(5):981-9. PubMed ID: 11029502
[TBL] [Abstract][Full Text] [Related]
11. Telomerase inhibitors in cancer therapy: current status and future directions.
Incles CM; Schultes CM; Neidle S
Curr Opin Investig Drugs; 2003 Jun; 4(6):675-85. PubMed ID: 12901225
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Tárkányi I; Aradi J
Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
[TBL] [Abstract][Full Text] [Related]
13. Telomerase and telomeres: from basic biology to cancer treatment.
Helder MN; Wisman GB; van der Zee GJ
Cancer Invest; 2002; 20(1):82-101. PubMed ID: 11855380
[TBL] [Abstract][Full Text] [Related]
14. Telomerase and its potential for therapeutic intervention.
Phatak P; Burger AM
Br J Pharmacol; 2007 Dec; 152(7):1003-11. PubMed ID: 17603541
[TBL] [Abstract][Full Text] [Related]
15. Targeting telomeres and telomerase.
De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
[TBL] [Abstract][Full Text] [Related]
16. Telomerase Inhibitors from Natural Products and Their Anticancer Potential.
Ganesan K; Xu B
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267203
[TBL] [Abstract][Full Text] [Related]
17. Agents that target telomerase and telomeres.
Raymond E; Sun D; Chen SF; Windle B; Von Hoff DD
Curr Opin Biotechnol; 1996 Dec; 7(6):583-91. PubMed ID: 8939642
[TBL] [Abstract][Full Text] [Related]
18. Prospects for anti-neoplastic therapies based on telomere biology.
Stewart SA; Hahn WC
Curr Cancer Drug Targets; 2002 Mar; 2(1):1-17. PubMed ID: 12188917
[TBL] [Abstract][Full Text] [Related]
19. Telomerase inhibitors for the treatment of cancer: the current perspective.
Perry PJ; Arnold JR; Jenkins TC
Expert Opin Investig Drugs; 2001 Dec; 10(12):2141-56. PubMed ID: 11772310
[TBL] [Abstract][Full Text] [Related]
20. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
Rankin AM; Faller DV; Spanjaard RA
Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
